Dissemination of clinical trial results following trial primary completion date for all, lead, paediatric and adult trials
| All trials | Lead trials | Paediatric trials | Adult trials | |||||
| Total | 305 | 100% | 75 | 100% | 53 | 100% | 248 | 100% |
| Timely dissemination: | ||||||||
| Posting summary results within 12 months of PCD* | 12 | 3.9% | 1 | 1.3% | 4 | 7.5% | 8 | 3.2% |
| Publishing results within 24 months of PCD† | 102 | 33.4% | 33 | 44.0% | 18 | 34.0% | 82 | 33.1% |
| Posting and/or publishing results‡ | 110 | 36.1% | 34 | 45.3% | 20 | 37.7% | 88 | 35.5% |
| Posting and publishing results§ | 4 | 1.3% | 0 | 0.0% | 2 | 3.8% | 2 | 0.8% |
All the percentages calculated on the total numbers for all, lead, paediatric or adult trials.
*Study results posted on ClinicalTrials.gov within 12 months after PCD.
†Study results published as a journal publication before PCD or within 24 months after PCD.
‡Study results posted on ClinicalTrials.gov within 12 months after PCD and/or published as a journal publication before PCD or within 24 months after PCD.
§Study results posted on ClinicalTrials.gov within 12 months after PCD and published as a journal publication before PCD or within 24 months after PCD.
PCD, primary completion date.